Overview
- Description
The company develops an epigenetic blood test for early Alzheimer's detection using next-generation sequencing to aid diagnosis and accelerate drug discovery.
- Website
- Country
- Spain
- Sector
- Medical Technologies
Engage with ADmit Therapeutics S.L.*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.